HENNIG ARZNEIMITTEL

Founded: 1898 • Age: 128 yrs Acquired By Polifarma
Generic drugs are manufactured and supplied by Hennig Arzneimittel.

About HENNIG ARZNEIMITTEL

HENNIG ARZNEIMITTEL is a company founded in 1898 was acquired by Polifarma in February 2025.. The company has 335 employees as of December 31, 2021.

  • Employees 335 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Hennig Arzneimittel Gmbh & Co. Kg
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    335

    as on Dec 31, 2021

  • Acquired by
    Polifarma

    (Feb 17, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of HENNIG ARZNEIMITTEL
Headcount 200-500
Employee Profiles 5
Employee Profiles
People
Dr. Anna Reimer
Regulatory Affairs Manager CMC
People
Katrin Wengenroth
Head Of Regulatory Affairs CMC
People
Laura Glück
GMP Master Documentation

Unlock access to complete

Funding Insights of HENNIG ARZNEIMITTEL

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in HENNIG ARZNEIMITTEL

HENNIG ARZNEIMITTEL has secured backing from 1 investor. Prominent investors backing the company include Polifarma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Polifarma S.p.A. is engaged in developing pharmaceutical solutions.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by HENNIG ARZNEIMITTEL

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - HENNIG ARZNEIMITTEL

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Hennig Arzneimittel Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of HENNIG ARZNEIMITTEL

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Hennig Arzneimittel

Frequently Asked Questions about HENNIG ARZNEIMITTEL

When was HENNIG ARZNEIMITTEL founded?

HENNIG ARZNEIMITTEL was founded in 1898.

How many employees does HENNIG ARZNEIMITTEL have?

As of Dec 31, 2021, the latest employee count at HENNIG ARZNEIMITTEL is 335.

What does HENNIG ARZNEIMITTEL do?

Hennig Arzneimittel was founded in 1898 as a pharmaceutical entity focused on generic drugs. Operations center on the production and distribution of affordable medications, including various therapeutic categories. The company maintains manufacturing facilities in Germany, adhering to regulatory standards for quality and safety. Services encompass formulation development and supply chain management for healthcare providers across Europe. No international expansions beyond the region are noted.

Who are HENNIG ARZNEIMITTEL's investors?

HENNIG ARZNEIMITTEL has 1 investor. Key investors include Polifarma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available